Cargando…

Immunotherapies in Huntington's disease and α-Synucleinopathies

Modulation of immune activation using immunotherapy has attracted considerable attention for many years as a potential therapeutic intervention for several inflammation-associated neurodegenerative diseases. However, the efficacy of single-target immunotherapy intervention has shown limited or no ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fatoba, Oluwaseun, Ohtake, Yosuke, Itokazu, Takahide, Yamashita, Toshihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052383/ https://www.ncbi.nlm.nih.gov/pubmed/32161599 http://dx.doi.org/10.3389/fimmu.2020.00337

Ejemplares similares

Humanized Anti-RGMa Antibody Treatment Promotes Repair of Blood-Spinal Cord Barrier Under Autoimmune Encephalomyelitis in Mice
por: Hirata, Takeshi, et al.
Publicado: (2022)

Meningeal T cells function in the central nervous system homeostasis and neurodegenerative diseases
por: Abbaoui, Abdellatif, et al.
Publicado: (2023)

Immunotherapy Targeting Neurodegenerative Proteinopathies: α-Synucleinopathies and Tauopathies
por: Shin, Junghwan, et al.
Publicado: (2020)

Identification of the Neogenin-Binding Site on the Repulsive Guidance Molecule A
por: Itokazu, Takahide, et al.
Publicado: (2012)

Interleukin-17A regulates ependymal cell proliferation and functional recovery after spinal cord injury in mice
por: Miyajima, Hisao, et al.
Publicado: (2021)

Dysfunction of the noradrenergic system drives inflammation, α-synucleinopathy, and neuronal loss in mouse colon
por: Song, Sheng, et al.
Publicado: (2023)

Neuroplasticity related to chronic pain and its modulation by microglia
por: Hiraga, Shin-ichiro, et al.
Publicado: (2022)

Temporal Changes in Cell Marker Expression and Cellular Infiltration in a Controlled Cortical Impact Model in Adult Male C57BL/6 Mice
por: Jin, Xuemei, et al.
Publicado: (2012)

A novel aquaporin-4-associated optic neuritis rat model with severe pathological and functional manifestations
por: Morita, Yuko, et al.
Publicado: (2022)

Autonomic Dysfunction in α-Synucleinopathies
por: Mendoza-Velásquez, José Javier, et al.
Publicado: (2019)

Selective vulnerability in α-synucleinopathies
por: Alegre-Abarrategui, Javier, et al.
Publicado: (2019)

Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
por: Nimmo, Jacqui T., et al.
Publicado: (2020)

Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies
por: Lemos, Miguel, et al.
Publicado: (2020)

Neurons and Glia Interplay in α-Synucleinopathies
por: Mavroeidi, Panagiota, et al.
Publicado: (2021)

Autophagy in α-Synucleinopathies—An Overstrained System
por: Fellner, Lisa, et al.
Publicado: (2021)

Disease modifying effect of adiponectin in model of α-synucleinopathies
por: Sekiyama, Kazunari, et al.
Publicado: (2014)

Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
por: Kallab, Martin, et al.
Publicado: (2018)

Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
por: Nimmo, Jacqui T., et al.
Publicado: (2023)

The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
por: Deyell, Jacob S., et al.
Publicado: (2023)

Drug Targeting of α-Synuclein Oligomerization in Synucleinopathies
por: Outeiro, Tiago Fleming, et al.
Publicado: (2008)

Leukotriene Signaling as a Target in α-Synucleinopathies
por: Strempfl, Katharina, et al.
Publicado: (2022)

Gaucher Disease and the Synucleinopathies
por: Hruska, Kathleen S., et al.
Publicado: (2006)

Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
por: Alecu, Irina, et al.
Publicado: (2019)

Astrocytes in Neurodegenerative Diseases: A Perspective from Tauopathy and α-Synucleinopathy
por: Wang, Peng, et al.
Publicado: (2021)

Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease
por: Miller, Sean J., et al.
Publicado: (2022)

STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy
por: Hinkle, Jared T., et al.
Publicado: (2022)

Propagative α-synuclein seeds as serum biomarkers for synucleinopathies
por: Okuzumi, Ayami, et al.
Publicado: (2023)

α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
por: Bigi, Alessandra, et al.
Publicado: (2023)

α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies
por: Abdelkarim, Hazem, et al.
Publicado: (2018)

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
por: Kawahata, Ichiro, et al.
Publicado: (2022)

α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
por: Schmitz, Matthias, et al.
Publicado: (2023)

Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy
por: Spencer, Brian, et al.
Publicado: (2017)

Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
por: Kim, Changyoun, et al.
Publicado: (2018)

Neuroinflammation in Huntington’s disease: From animal models to clinical therapeutics
por: Jia, Qingqing, et al.
Publicado: (2022)

α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies
por: Mizuno, Hideya, et al.
Publicado: (2010)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
por: Sekigawa, Akio, et al.
Publicado: (2015)

Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies
por: Trošt, Maja, et al.
Publicado: (2019)

ATPase Thorase Deficiency Causes α-Synucleinopathy and Parkinson’s Disease-like Behavior
por: Gao, Fei, et al.
Publicado: (2022)

Comparative proteomic analysis highlights metabolic dysfunction in α-synucleinopathy
por: Sarkar, Souvarish, et al.
Publicado: (2020)

Cellular Milieu Imparts Distinct Pathological α-Synuclein Strains in α-Synucleinopathies
por: Peng, Chao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rgvm7eqdn7ahh25uhcbmcq70fa